Service providers

Amplycell

Solution provided
Technological/Validation solutions
Supplier indentity
General description
AmplyCell is based in the Liege Science Park, Belgium, a highly stimulating Biotech environment. The company has been developing the AMPLY™ Technology for cell line stimulation since 2009 while the company has been officialy founded in April 2014.
Type of supplier
Bioprocess Solutions Provider, Service Provider - CMO / CRO
Sector of activity:
Biomanufacturing, Biotechnology sector, Drug Discovery / Research & Development, Rare Diseases, Vaccines
Activity description
Services provided
AmplyCell offers the AMPLY™ Technology as a service that increases in a permanent way cell line productivity and stability, allowing cost-effective and efficient GMP manufacturing of recombinant protein, difficult-to-express New Biological Entities and Biosimilars drugs. AMPLY™ Technology is a service solution that consists in physical stimulation treatments that improve cell line metabolism for Biologics manufacturing in cell line such as Chinese Hamster Ovary (AMPLY™CHO cells), Human Embryonic Kidney (AMPLY™ HEK293 cells), hybridomas, yeast, ... AMPLY™ Technology comes either as a unique solution or in synergy with cell culture media optimization, searching for cell culture parameters, and the use of gene-altering elements.
Terms of availability for SMEs
No
Quality labels and accreditations
All traceability aspects in place including procedures and records. Currently setting ISO9001
Contact information
Name
Geoffrey Holsbeek
Function
CEO
Phone number
+32497773177
Email address
Website
http://www.amplycell.com
Address
Avenue Hippocrate 5
4000 Liège
Belgium

Agenda

August 2022

Mo Tu We Th Fr Sa Su
1
 
2
 
3
 
4
 
5
 
6
 
7
 
8
 
9
 
10
 
11
 
12
 
13
 
14
 
15
 
16
 
17
 
18
 
19
 
20
 
21
 
22
 
23
 
24
 
25
 
26
 
27
 
28
 
29
 
30
 
31
 
 
 
 
 

August 2022